PIH14 COST-EFFECTIVENESS OF A HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLESTIMULATING HORMONE (RFSH) IN PATIENTS PARTICIPATING IN AN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAM
May 1, 2010, 00:00
10.1016/S1098-3015(10)72891-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)72891-6/fulltext
Title :
PIH14 COST-EFFECTIVENESS OF A HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLESTIMULATING HORMONE (RFSH) IN PATIENTS PARTICIPATING IN AN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72891-6&doi=10.1016/S1098-3015(10)72891-6
First page :
Section Title :
Open access? :
No
Section Order :
464